Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
KUNLUN ENERGY
00135
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 63.02%42.43M | -28.44%32.02M | -72.71%26.03M | -2.77%44.75M | 10.53%95.36M | 28.45%46.03M | 14.74%86.28M | -52.73%35.83M | -38.50%75.2M | 1.65%75.81M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 9.29%-3.2M | -53.69%-1.85M | 8.09%-3.53M | 49.71%-1.21M | -9.12%-3.84M | -42.87%-2.4M | 29.17%-3.52M | 13.73%-1.68M | -20.86%-4.97M | -3,140.00%-1.94M |
| Revaluation surplus: | -9,850.00%-2.19M | -249.51%-456K | 97.64%-22K | 267.58%305K | -137.50%-931K | 7.61%-182K | -609.09%-392K | -98.99%-197K | 352.94%77K | ---99K |
| -Other fair value changes | -9,850.00%-2.19M | -249.51%-456K | 97.64%-22K | 267.58%305K | -137.50%-931K | 7.61%-182K | -609.09%-392K | -98.99%-197K | 352.94%77K | ---99K |
| Asset sale loss (gain): | 39.30%-207K | 100.80%38K | 85.59%-341K | ---4.72M | -3,022.22%-2.37M | ---- | 242.11%81K | ---- | -416.67%-57K | -25.00%3K |
| -Loss (gain) from sale of subsidiary company | 69.13%-167K | ---- | 76.35%-541K | ---4.74M | -5,820.00%-2.29M | ---- | --40K | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -312.35%-172K | --71K | --81K | ---- | ---- | ---- | ---- | ---- | -183.33%-15K | -25.00%3K |
| -Loss (gain) from selling other assets | 10.92%132K | -306.25%-33K | 250.63%119K | --16K | -292.68%-79K | ---- | 197.62%41K | ---- | ---42K | ---- |
| Depreciation and amortization: | 13.53%22.04M | -19.10%8.42M | 14.27%19.41M | 22.81%10.41M | 48.49%16.99M | 62.63%8.47M | 102.69%11.44M | 109.07%5.21M | 39.94%5.65M | 16.01%2.49M |
| -Amortization of intangible assets | 77.02%13.52M | 3.98%4.05M | 22.71%7.64M | 30.14%3.9M | 90.13%6.22M | 105.00%2.99M | 157.92%3.27M | 281.20%1.46M | 76.50%1.27M | 23.95%383K |
| Financial expense | -41.82%2.14M | -22.63%1.55M | 3.23%3.67M | 30.44%2M | 135.63%3.56M | 193.30%1.53M | 128.79%1.51M | 65.71%522K | -88.30%660K | -89.56%315K |
| Exchange Loss (gain) | 303.62%788K | 209.43%232K | -63.29%-387K | -105.83%-212K | -39.41%-237K | 62.55%-103K | -104.63%-170K | -118.58%-275K | -60.33%3.67M | --1.48M |
| Special items | -122.91%-1.41M | 60.66%882K | -2.98%6.15M | -77.71%549K | -60.59%6.34M | -76.77%2.46M | -83.17%16.08M | --10.6M | --95.51M | ---- |
| Operating profit before the change of operating capital | 18.46%60.39M | -21.28%40.83M | -55.62%50.98M | -7.06%51.87M | 3.20%114.87M | 11.58%55.81M | -36.66%111.31M | -35.92%50.02M | 28.15%175.73M | -2.05%78.05M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | -292.43%-98.55M | 48.17%-52.76M | 170.41%51.21M | -5,269.51%-101.81M | 63.67%-72.73M | 97.92%-1.9M | -20.91%-200.19M | -29.72%-90.99M | -110.78%-165.57M | -160.23%-70.15M |
| Accounts payable increase (decrease) | 253.07%70.38M | 201.89%51.91M | -164.93%-45.98M | -232.51%-50.94M | -35.70%70.82M | 108.36%38.44M | 87.92%110.14M | -45.01%18.45M | 614.72%58.61M | 327.70%33.55M |
| prepayments (increase)decrease | -47.37%92.53M | -86.48%19.09M | 264.42%175.81M | 249.98%141.21M | -360.02%-106.93M | -168.42%-94.15M | 121.14%41.12M | 187.74%137.62M | 15.89%-194.49M | -239.66%-156.86M |
| Special items for working capital changes | 910.58%128.7M | 1,375.25%34.67M | 60.01%-15.88M | 37.58%-2.72M | -15.41%-39.7M | -221.24%-4.36M | -566.19%-34.4M | 98.76%-1.36M | 197.42%7.38M | -4,425.16%-109.01M |
| Cash from business operations | 17.26%253.46M | 149.23%93.74M | 741.95%216.15M | 711.38%37.61M | -220.30%-33.67M | -105.41%-6.15M | 123.65%27.99M | 150.68%113.74M | 34.82%-118.33M | -1,973.08%-224.41M |
| Other taxs | -9.63%-12.22M | 54.70%-2.88M | 31.35%-11.15M | 11.78%-6.36M | -194.90%-16.23M | -24.87%-7.21M | 0.49%-5.51M | -7.38%-5.78M | -28.00%-5.53M | -24.45%-5.38M |
| Net cash from operations | 17.68%241.24M | 190.76%90.86M | 510.79%205M | 333.79%31.25M | -321.96%-49.9M | -112.38%-13.37M | 118.15%22.48M | 146.98%107.96M | 33.36%-123.87M | -3,100.71%-229.79M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -1.08%3.2M | 129.43%1.61M | -14.92%3.24M | -70.51%700K | 32.89%3.81M | 41.56%2.37M | -55.85%2.86M | -13.73%1.68M | 151.43%6.49M | 3,140.00%1.94M |
| Sale of fixed assets | 3,191.11%1.48M | --341K | --45K | ---- | ---- | ---- | -72.50%11K | ---- | -11.11%40K | --7K |
| Purchase of fixed assets | -119.76%-2.38M | -66.62%-1.31M | 71.87%-1.08M | 6.44%-785K | -31.76%-3.85M | -12.47%-839K | -6.84%-2.92M | 71.69%-746K | -5,370.00%-2.74M | -26,250.00%-2.64M |
| Purchase of intangible assets | 59.26%-1.71M | 33.03%-1.42M | 63.13%-4.19M | -16.49%-2.12M | 13.53%-11.36M | 73.41%-1.82M | -27.73%-13.14M | ---6.84M | -580.16%-10.28M | ---- |
| Sale of subsidiaries | -101.29%-6K | ---- | 122.44%465K | --2.57M | ---2.07M | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | -66.73%208.16M | 295.66%79.13M | 653.73%625.59M | -50.00%20M | -4.90%83M | 94.17%40M | -85.14%87.28M | --20.6M | 3.79%587.46M | ---- |
| Cash on investment | 78.20%-153.65M | -514.43%-122.89M | -936.56%-704.86M | 65.52%-20M | 29.53%-68M | -93.33%-58M | 83.93%-96.5M | ---30M | -5.35%-600.56M | ---- |
| Other items in the investment business | ---9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 157.07%46.1M | -12,436.29%-44.53M | -5,397.57%-80.79M | 101.97%361K | 106.81%1.53M | -19.42%-18.28M | -14.36%-22.41M | -2,138.45%-15.31M | -558.11%-19.59M | -868.54%-684K |
| Net cash before financing | 131.33%287.34M | 46.55%46.32M | 356.75%124.21M | 199.87%31.61M | -62,929.87%-48.38M | -134.16%-31.65M | 100.05%77K | 140.20%92.65M | 24.03%-143.46M | -3,075.06%-230.48M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -98.11%10M | -69.05%121.54M | -35.07%528.66M | 71.08%392.68M | 253.59%814.21M | 108.68%229.53M | -77.86%230.27M | -74.64%109.99M | 71.90%1.04B | 384.66%433.74M |
| Refund | 65.69%-170.71M | 45.30%-196.56M | 30.36%-497.6M | -200.49%-359.33M | -256.80%-714.56M | -99.34%-119.58M | 82.87%-200.27M | 88.14%-59.99M | -120.05%-1.17B | -509.35%-505.61M |
| Interest paid - financing | 41.82%-2.14M | 55.83%-1.55M | -3.23%-3.67M | -128.48%-3.5M | -135.63%-3.56M | -193.30%-1.53M | 17.17%-1.51M | -65.71%-522K | 66.41%-1.82M | 88.30%-315K |
| Dividends paid - financing | -177,139.29%-99.25M | ---- | 99.87%-56K | ---- | 29.66%-42.86M | 29.66%-42.86M | 42.45%-60.94M | 42.45%-60.94M | -605.91%-105.89M | -605.91%-105.89M |
| Absorb investment income | ---- | ---- | ---- | ---- | 100.00%1.17M | --1.17M | --585K | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---4.45M | ---4.45M | ---- | ---- | ---- | ---- | 77.40%-1.55M | ---- | 80.98%-6.86M | ---- |
| Pledged bank deposit (increase) decrease | ---- | ---- | --20M | ---- | ---- | 200.00%20M | -113.79%-20M | -123.53%-20M | 200.38%145M | 15,354.55%85M |
| Net cash from financing operations | -808.40%-272.7M | -444.04%-83.39M | -15.70%38.5M | -70.37%24.24M | 176.28%45.66M | 338.90%81.81M | 40.91%-59.87M | 63.71%-34.25M | -115.66%-101.32M | -734.38%-94.35M |
| Effect of rate | -303.62%-788K | -209.43%-232K | 63.29%387K | 105.83%212K | 39.41%237K | -17.60%103K | 104.63%170K | 108.45%125K | 60.33%-3.67M | ---1.48M |
| Net Cash | -91.00%14.65M | -166.36%-37.06M | 6,092.93%162.71M | 11.33%55.85M | 95.46%-2.72M | -14.11%50.16M | 75.57%-59.79M | 117.98%58.4M | -153.43%-244.78M | -9,021.88%-324.83M |
| Begining period cash | 110.69%310.44M | 110.69%310.44M | -1.65%147.35M | -1.65%147.35M | -28.47%149.83M | -28.47%149.83M | -54.26%209.45M | -54.26%209.45M | 4,997.32%457.89M | 4,997.32%457.89M |
| Cash at the end | 4.46%324.3M | 34.29%273.15M | 110.69%310.44M | 1.66%203.41M | -1.65%147.35M | -25.33%200.09M | -28.47%149.83M | 103.66%267.97M | -54.26%209.45M | 2,326.82%131.58M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | 15.33%354.25M | ---- | --307.17M | 28.96%249.07M | ---- | --193.15M | ---- | ---- | --312.18M |
| Cash and cash equivalent balance | ---- | 34.29%273.15M | ---- | --203.41M | ---- | ---- | -28.47%149.83M | ---- | -54.26%209.45M | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.